341 related articles for article (PubMed ID: 21114532)
1. Percutaneous patent foramen ovale closure using Helex and Amplatzer devices without intraprocedural echocardiographic guidance.
Siddiqui IF; Michaels AD
J Interv Cardiol; 2011 Jun; 24(3):271-7. PubMed ID: 21114532
[TBL] [Abstract][Full Text] [Related]
2. Patent foramen ovale closure without echocardiographic control: use of "standby" intracardiac ultrasound.
Hildick-Smith D; Behan M; Haworth P; Rana B; Thomas M
JACC Cardiovasc Interv; 2008 Aug; 1(4):387-91. PubMed ID: 19463334
[TBL] [Abstract][Full Text] [Related]
3. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
4. Single centre experience with GORE-HELEX septal occluder for closure of PFO.
Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell A; Wilson N; Ormerod O
Heart Lung Circ; 2009 Apr; 18(2):140-2. PubMed ID: 18294910
[TBL] [Abstract][Full Text] [Related]
5. Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder?
Fateh-Moghadam S; Steeg M; Dietz R; Bocksch W
Catheter Cardiovasc Interv; 2009 Feb; 73(3):361-6. PubMed ID: 19133676
[TBL] [Abstract][Full Text] [Related]
6. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
7. Late results after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism using the amplatzer PFO occluder without intraprocedural echocardiography: effect of device size.
Wahl A; Tai T; Praz F; Schwerzmann M; Seiler C; Nedeltchev K; Windecker S; Mattle HP; Meier B
JACC Cardiovasc Interv; 2009 Feb; 2(2):116-23. PubMed ID: 19463412
[TBL] [Abstract][Full Text] [Related]
8. Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography.
Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell AR; Wilson N; Ormerod OJ
Int J Cardiol; 2009 Jan; 131(3):438-40. PubMed ID: 18037512
[TBL] [Abstract][Full Text] [Related]
9. Comparison of residual shunt rate and complications across 6 different closure devices for patent foramen ovale.
Gevorgyan Fleming R; Kumar P; West B; Noureddin N; Rusheen J; Aboulhosn J; Tobis JM
Catheter Cardiovasc Interv; 2020 Feb; 95(3):365-372. PubMed ID: 31654558
[TBL] [Abstract][Full Text] [Related]
10. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
Thompson AJ; Hagler DJ; Taggart NW
Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
[TBL] [Abstract][Full Text] [Related]
11. Gore Helex septal occluder for percutaneous closure of patent foramen ovale associated with atrial septal aneurysm: short- and mid-term clinical and echocardiographic outcomes.
Musto C; Cifarelli A; Fiorilli R; De Felice F; Parma A; Pandolfi C; Confessore P; Bernardi L; Violini R
J Invasive Cardiol; 2012 Oct; 24(10):510-4. PubMed ID: 23043034
[TBL] [Abstract][Full Text] [Related]
12. Long-term transesophageal echocardiography after patent foramen ovale closure by BioSTAR and Amplatzer patent foramen ovale occluders.
Suligoj NC; Rojko M; Suligoj B; Zorc M; Kar S; Noc M
Catheter Cardiovasc Interv; 2020 Feb; 95(3):349-354. PubMed ID: 31131978
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
[TBL] [Abstract][Full Text] [Related]
14. A novel system for transcatheter closure of patent foramen ovale: clinical and echocardiographic outcome comparison with other contemporary devices.
Darsaklis K; Freixa X; Asgar A; Ibrahim R; Basmadjian A; DeGuise P; Garceau P
Can J Cardiol; 2014 Jun; 30(6):639-46. PubMed ID: 24882535
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale.
Hornung M; Bertog SC; Franke J; Id D; Taaffe M; Wunderlich N; Vaskelyte L; Hofmann I; Sievert H
Eur Heart J; 2013 Nov; 34(43):3362-9. PubMed ID: 23842846
[TBL] [Abstract][Full Text] [Related]
16. Periprocedural Outcomes of Fluoroscopy-Guided Patent Foramen Ovale Closure With Selective Use of Intracardiac Echocardiography.
Barker M; Muthuppalaniappan AM; Abrahamyan L; Osten MD; Benson LN; Bach Y; Ma J; Abraha N; Horlick E
Can J Cardiol; 2020 Oct; 36(10):1608-1615. PubMed ID: 32610094
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder).
Taaffe M; Fischer E; Baranowski A; Majunke N; Heinisch C; Leetz M; Hein R; Bayard Y; Büscheck F; Reschke M; Hoffmann I; Wunderlich N; Wilson N; Sievert H
Am J Cardiol; 2008 May; 101(9):1353-8. PubMed ID: 18435971
[TBL] [Abstract][Full Text] [Related]
19. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
20. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
